Clinical Report: Home Tonometry Benefits and Limitations in Glaucoma Care

Overview

Home tonometry devices, such as the FDA-approved iCare Home and iCare Home2, provide valuable insights into intraocular pressure (IOP) fluctuations throughout the day, which are often missed during clinic visits. While these devices enhance patient engagement and aid in detecting peak IOP and pressure variability, limitations include cost, patient dexterity requirements, and potential anxiety from frequent monitoring.

Background

Intraocular pressure remains the only modifiable risk factor for glaucoma progression, with clinic-based measurements offering only single time-point assessments that may not capture true diurnal IOP variations. Many patients experience peak IOP during early morning hours, often outside clinic hours, leading to potential underestimation of pressure fluctuations. Home tonometry devices have been developed to provide more comprehensive IOP profiles, facilitating improved clinical decision-making and patient management.

Data Highlights

Studies show that up to one-third of patients have peak IOP measurements outside clinic hours when monitored with iCare Home devices. Systematic reviews demonstrate strong correlation between iCare Home and Goldmann applanation tonometry (GAT), though discrepancies exist, especially at lower and higher IOP ranges and in eyes with thicker corneas. The water drinking test correlates strongly with peak IOP measured by iCare Home, offering an alternative for patients unable to perform home tonometry.

Key Findings

• Home tonometry allows detection of IOP peaks and fluctuations missed during office visits, aiding in identifying patients with pressure-dependent progression.
• The iCare Home2 device offers advantages including supine position measurements and mobile app integration for data tracking.
• Home monitoring can objectively assess therapeutic intervention effects earlier than structural or functional testing.
• Patient engagement and medication adherence may improve with home IOP monitoring, similar to home blood pressure monitoring in hypertension.
• Cost and lack of insurance coverage remain significant barriers to widespread adoption of home tonometry.
• Physical dexterity and patient training needs limit usability for some individuals; additional support may be required.
• Some patients may experience increased anxiety from frequent measurements, necessitating counseling and reassurance.

Clinical Implications

Incorporating home tonometry into glaucoma management can enhance detection of clinically relevant IOP fluctuations and improve individualized treatment decisions. Clinicians should consider patient ability, cost, and potential psychological impact when recommending home monitoring. Alternative methods like the water drinking test may be useful for patients unable to perform self-tonometry.

Conclusion

Home tonometry represents a valuable tool for comprehensive IOP assessment and patient engagement in glaucoma care, though practical limitations must be addressed to optimize its clinical utility. Tailored patient education and support are essential to maximize benefits and minimize challenges.

Related Resources & Content

1. Clinical considerations for incorporating home IOP monitoring into glaucoma care
2. Systematic review of iCare Home and Goldmann applanation tonometry correlation
3. Study on peak IOP detection outside clinic hours using iCare Home
4. Water drinking test correlation with iCare Home peak IOP measurements